Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Curevac N.V.
(NQ:
CVAC
)
3.670
-0.330 (-8.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Curevac N.V.
< Previous
1
2
3
4
5
6
7
Next >
CureVac Outlines Upcoming Catalysts For Vaccine Programs
January 10, 2022
Ahead of J.P. Morgan Healthcare Conference, CureVac BV (NASDAQ: CVAC) outlined the timeline for its vaccine programs. CureVac's preclinical second-...
Via
Benzinga
The 'Highly Mutated Virus' Signals A Need For Annual Shots: BioNTech CEO
December 03, 2021
The omicron variant signals a need for annual Covid shots, BioNTech's CEO said.
Via
Investor's Business Daily
56 Biggest Movers From Friday
November 29, 2021
Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on...
Via
Benzinga
Why CureVac Shares Are Falling
October 15, 2021
CureVac BV (NASDAQ: CVAC) shares are trading lower after the company and Bayer reportedly terminated their vaccine manufacturing partnership. More news came around 1:20 pm...
Via
Benzinga
Unusual Options Activity Insight: CureVac
August 11, 2021
CureVac (NASDAQ:CVAC) shares experienced unusual options ...
Via
Benzinga
48 Stocks Moving In Friday's Mid-Day Session
November 26, 2021
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded...
Via
Benzinga
CureVac (CVAC) Q3 2021 Earnings Call Transcript
November 19, 2021
CVAC earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
CureVac's COVID-19 Vax Shows Comparable Antibody Levels To Pfizer/BioNTech's Shot In Animal Study
November 18, 2021
CureVac BV (NASDAQ: CVAC) has announced the online publication of the extended preclinical study of the second-generation vaccine candidate, CV2CoV, jointly developed with...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
November 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Roche's Spark Subsidiary Reports Positive Phase 1/2 Data For Hemophilia...
Via
Benzinga
Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage
October 18, 2021
Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral...
Via
Talk Markets
Why CureVac Stock Is Tumbling Today
October 12, 2021
The company is throwing in the towel on its first-generation COVID-19 vaccine candidate.
Via
The Motley Fool
Exposures
COVID-19
Why CureVac Shares Are Trading Lower Today
October 12, 2021
CureVac NV (NASDAQ: CVAC) is trading lower Tuesday after the company announced it will focus its COVID-19 vaccine development towards the development of second-gen mRNA...
Via
Benzinga
Exposures
COVID-19
51 Biggest Movers From Friday
October 18, 2021
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it...
Via
Benzinga
54 Biggest Movers From Friday
October 04, 2021
Check out these big penny stock gainers and losers Losers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc....
Via
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...
Via
Benzinga
Vaccine Stocks: Why MRNA, VXRT, CVAC and NVAX Stocks Need a Band-Aid Today
October 01, 2021
Today, vaccine stocks are taking a massive hit as investors price in the potential effect of oral medications for Covid-19 on this sector.
Via
InvestorPlace
Exposures
COVID-19
Why Moderna, Novavax And Other COVID-19 Vaccine Stocks Are Plummeting
October 01, 2021
The COVID-19 pandemic proved to be a boon for many biopharma companies that benefited from their foray into the development of vaccines and/or treatments against the novel...
Via
Benzinga
Exposures
COVID-19
Breaking Down The Inflation Numbers Draws Attention To Oil Prices
September 15, 2021
Oil futures (/CL) are up 1% this morning ahead of the crude oil inventories report. While the NY Empire State Manufacturing Index was nearly double forecast. However,...
Via
Benzinga
Exposures
Fossil Fuels
CureVac Shares Fall After Cutting COVID-19 Vaccine Production Plans
September 14, 2021
CureVac BV has canceled contract manufacturing deals for its experimental COVID-19 vaccine with two prospective partners.
Via
Talk Markets
Exposures
COVID-19
CureVac Shares Fall After Cutting COVID-19 Vaccine Production Plans
September 14, 2021
CureVac BV (NASDAQ: CVAC) has canceled contract manufacturing deals for its experimental COVID-19 vaccine with two prospective partners. The Company would...
Via
Benzinga
Exposures
COVID-19
Why CureVac's Stock Is Down During Today's Session
September 14, 2021
CureVac (NASDAQ:CVAC) shares are trading lower after the company announced its strategic decision to adjust the long-term footprint of the external European...
Via
Benzinga
Glaxo, SK Bioscience Start COVID-19 Vaccine Trial Against AstraZeneca Shot
August 31, 2021
GlaxoSmithKline Plc (NYSE: GSK) has started Phase 3 clinical study for a COVID-19 vaccine candidate designed by South Korean drugmaker SK Bioscience Co. The...
Via
Benzinga
Exposures
COVID-19
Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?
August 27, 2021
It isn't likely.
Via
The Motley Fool
Surprise! Here's the Cheapest COVID Vaccine Stock on the Market Right Now
August 19, 2021
The least expensive COVID-19 vaccine stock right now isn't one of the leaders in the market -- at least not yet.
Via
The Motley Fool
Exposures
COVID-19
4 High-Yield Dividend Stocks to Boost Your Dividend Income
August 17, 2021
Dividends paid by GlaxoSmithKline plc, Vector Group Ltd, Star Group, L.P., and Ennis, Inc translate to high yields at their current price levels.
Via
Talk Markets
Boehringer Ingelheim Scraps Lung Cancer Program With CureVac
August 16, 2021
CureVac NV (NASDAQ: CVAC) disclosed among the COVID-19 vaccine highlights that €465 million oncology partnership with Boehringer Ingelheim had been terminated...
Via
Benzinga
Exposures
COVID-19
Vaccine Stocks: The Latest News Moving BNTX, CVAC, NVAX Stocks Today
August 16, 2021
Today, investors in vaccine stocks are seeing a lot of red, as investors seem to be taking some risk off the table ahead of Fed tapering.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
26 Stocks Moving in Thursday's Pre-Market Session
August 05, 2021
Gainers Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares rose 34% to $5.48 in pre-market trading after dropping around 15% on Wednesday. Ensysce Biosciences recently appointed...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.